… es, including depression (see section 4.5 and 4.8). Early recognition of relevant symptoms is important, especially in predisposed patients. In such cases, drug discontinuation should be considered.
Diltiazem has an inhibitory effect on intestinal motility. Therefore, it should be used with caution in patients at risk of developing an intestinal obstruction.
Careful monitoring is necessary in patients with latent or manifest diabetes mellitus due to a possible increase in blood glucose.
The use of diltiazem may induce bronchospasm, including asthma agg …
Identical in all 4 labels. Surrounding text shown from Ethypharm UK Ltd.
… ssociated with mood changes, including depression. Early recognition of relevant symptoms is important, especially in predisposed patients. In such cases, drug discontinuation should be considered.
Like other calcium channel antagonists, diltiazem has an inhibitory effect on intestinal motility. Therefore it should be used with caution in patients at risk to develop an intestinal obstruction. Tablet residues from slow release formulations of the product may pass into the patient's stools; however, this finding has no clinical relevance.
Careful monitoring is necessary in patients with latent or manifest diabetes mellitus due to a possible increase in blood glucose.
The use of diltiazem may induce bronchospasm, including asthma agg …
Identical in all 3 labels. Surrounding text shown from Zentiva.
… ring, particularly of heart rate, should be carried out at the beginning of treatment.
Calcium channel blocking agents, such as diltiazem, may be associated with mood changes, including depression.
Like other calcium channel antagonists, diltiazem has an inhibitory effect on intestinal motility. Therefore it should be used with caution in patients at risk of developing an intestinal obstruction. Tablet residues from slow release formulations of the product may pass into the patient's stools; however, this finding has no clinical relevance.
This medicine contains less than 1 mmol sodium (23 mg) per capsule, that is to say essentially 'sodium-free'.
Identical in both labels. Surrounding text shown from Napp Pharmaceuticals Limited.